Diana B. Cherbavaz

A 17-gene Assay to Predict Prostate Cancer Aggressiveness in the Context of Gleason Grade Heterogeneity, Tumor Multifocality, and Biopsy Undersampling

Eric A. Klein, Matthew R. Cooperberg, Cristina Magi‐Galluzzi et al. · European Urology · 2014 · 650 citations

Gleason Grade Heterogeneity, Urology, Oncology +9

A Multigene Expression Assay to Predict Local Recurrence Risk for Ductal Carcinoma In Situ of the Breast

Lawrence J. Solin, Robert P. Gray, Frederick L. Baehner et al. · JNCI Journal of the National Cancer Institute · 2013 · 513 citations · Full text

Analytical validation of the Oncotype DX prostate cancer assay – a clinical RT-PCR assay optimized for prostate needle biopsies

Dejan Knezevic, Audrey D. Goddard, Nisha Natraj et al. · BMC Genomics · 2013 · 323 citations · Full text

A population-based validation study of the DCIS Score predicting recurrence risk in individuals treated by breast-conserving surgery alone

Eileen Rakovitch, Sharon Nofech‐Mozes, Wedad Hanna et al. · Breast Cancer Research and Treatment · 2015 · 231 citations · Full text

21-Gene Recurrence Score and Locoregional Recurrence in Node-Positive/ER-Positive Breast Cancer Treated With Chemo-Endocrine Therapy

Eleftherios P. Mamounas, Qing Liu, Soonmyung Paik et al. · JNCI Journal of the National Cancer Institute · 2017 · 127 citations · Full text